Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 18 de 18
Filtrar
1.
ISME J ; 15(2): 577-591, 2021 02.
Artículo en Inglés | MEDLINE | ID: mdl-33087860

RESUMEN

Microbiota-accessible carbohydrates (MACs) are powerful modulators of microbiota composition and function. These substrates are often derived from diet, such as complex polysaccharides from plants or human milk oligosaccharides (HMOs) during breastfeeding. Host-derived mucus glycans on gut-secreted mucin proteins serve as a continuous endogenous source of MACs for resident microbes; here we investigate the potential role of purified, orally administered mucus glycans in maintaining a healthy microbial community. In this study, we liberated and purified O-linked glycans from porcine gastric mucin and assessed their efficacy in shaping the recovery of a perturbed microbiota in a mouse model. We found that porcine mucin glycans (PMGs) and HMOs enrich for taxonomically similar resident microbes. We demonstrate that PMGs aid recovery of the microbiota after antibiotic treatment, suppress Clostridium difficile abundance, delay the onset of diet-induced obesity, and increase the relative abundance of resident Akkermansia muciniphila. In silico analysis revealed that genes associated with mucus utilization are abundant and diverse in prevalent gut commensals and rare in enteric pathogens, consistent with these glycan-degrading capabilities being selected for during host development and throughout the evolution of the host-microbe relationship. Importantly, we identify mucus glycans as a novel class of prebiotic compounds that can be used to mitigate perturbations to the microbiota and provide benefits to host physiology.


Asunto(s)
Microbiota , Mucinas , Animales , Dieta , Polisacáridos , Porcinos , Verrucomicrobia
2.
J Neurol Sci ; 307(1-2): 22-9, 2011 Aug 15.
Artículo en Inglés | MEDLINE | ID: mdl-21663922

RESUMEN

OBJECTIVE: To examine genetic associations of polymorphisms in the dopamine receptor D2 (DRD2) and D3 (DRD3) genes with risk of Parkinson's disease (PD). METHODS: The study included 1325 newly diagnosed patients with PD and 1735 controls from a consortium of five North American case-control studies. We collected risk factor information by in-person or telephone interview. Six DRD2 and two DRD3 polymorphisms were genotyped using a common laboratory. Odds ratios were estimated using logistic regression. RESULTS: Among non-Hispanic whites, homozygous carriers of Taq1A DRD2 (rs1800497) polymorphism had an increased risk of PD compared to homozygous wildtype carriers (OR=1.5, 95% CI 1.0-2.3). In contrast, the direction of association for Taq1A polymorphism was opposite for African-Americans, showing an inverse association with PD risk (OR=0.10, 95% CI 0.2-0.7). Among white Hispanics who carried two alleles, the Ser9Gly DRD3 (rs6280) polymorphism was associated with a decreased risk of PD (OR=0.4, 95% CI 0.2-0.8). The inverse association of smoking with PD risk was not modified by any of the DRD2 or DRD3 polymorphisms. CONCLUSIONS: DRD2 polymorphisms are unlikely to be true disease-causing variants; however, three DRD2 polymorphisms (including Taq1A) may be in linkage disequilibrium with possible disease associated variants in the DRD2-ANKK1-NCAM1-TTC12 gene cluster.


Asunto(s)
Predisposición Genética a la Enfermedad/genética , Enfermedad de Parkinson/etnología , Enfermedad de Parkinson/genética , Polimorfismo Genético/genética , Receptores de Dopamina D2/genética , Receptores de Dopamina D3/genética , Negro o Afroamericano/genética , Anciano , Estudios de Casos y Controles , Femenino , Tamización de Portadores Genéticos , Predisposición Genética a la Enfermedad/etnología , Genotipo , Hispánicos o Latinos/genética , Humanos , Masculino , Persona de Mediana Edad , Familia de Multigenes/genética , América del Norte/epidemiología , Enfermedad de Parkinson/epidemiología , Medición de Riesgo/métodos , Población Blanca/genética
3.
Eur J Neurol ; 18(5): 756-65, 2011 May.
Artículo en Inglés | MEDLINE | ID: mdl-21281405

RESUMEN

BACKGROUND AND PURPOSE: In 1-methyl-4-phenyl 1,2,3,6-tetrahydropyridine animal models of Parkinson's disease (PD), caffeine protects neurons by blocking the adenosine receptor A2A (ADORA2A). Caffeine is primarily metabolized by cytochrome P450 1A2 (CYP1A2). Our objective was to examine whether ADORA2A and CYP1A2 polymorphisms are associated with PD risk or modify the caffeine-PD association. METHODS: Parkinson's Epidemiology and Genetic Associations Studies in the United States (PEGASUS) included five population-based case-control studies. One laboratory genotyped four ADORA2A and three CYP1A2 polymorphisms in 1325 PD cases and 1735 age- and sex-matched controls. Information regarding caffeine (coffee) consumption and other lifestyle factors came from structured in-person or telephone interviews. Odds ratios (OR) and 95% confidence intervals (CI) were estimated using logistic regression. RESULTS: Two ADORA2A polymorphisms were inversely associated with PD risk - rs71651683, a 5' variant (adjusted allelic OR = 0.51, 95% CI 0.33-0.80, permutation-adjusted P = 0.015) and rs5996696, a promoter region variant (adjusted OR for AC and CC genotypes compared with the AA wild-type genotype were 0.76 (95% CI 0.57-1.02) and 0.37 (95% CI 0.13-1.01), respectively (permutation-adjusted P for trend = 0.04). CYP1A2 polymorphisms were not associated with PD risk; however, the coffee-PD association was strongest among subjects homozygous for either variant allele rs762551 (P(interaction) = 0.05) or rs2470890 (P(interaction) = 0.04). CONCLUSION: In this consortium study, two ADORA2A polymorphisms were inversely associated with PD risk, but there was weak evidence of interaction with coffee consumption. In contrast, the coffee-PD association was strongest among slow metabolizers of caffeine who were homozygous carriers of the CYP1A2 polymorphisms.


Asunto(s)
Cafeína/metabolismo , Citocromo P-450 CYP1A2/genética , Predisposición Genética a la Enfermedad/genética , Fármacos Neuroprotectores/farmacología , Enfermedad de Parkinson/genética , Receptor de Adenosina A2A/genética , Anciano , Cafeína/uso terapéutico , Estudios de Casos y Controles , Estudios de Cohortes , Femenino , Predisposición Genética a la Enfermedad/epidemiología , Humanos , Masculino , Persona de Mediana Edad , Fármacos Neuroprotectores/metabolismo , Enfermedad de Parkinson/tratamiento farmacológico , Enfermedad de Parkinson/epidemiología , Inhibidores de Fosfodiesterasa/metabolismo , Inhibidores de Fosfodiesterasa/uso terapéutico
5.
Plant Cell ; 1(8): 747-755, 1989 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-12359909

RESUMEN

Pectic fragments of cell wall polysaccharides, released from the walls of suspension-cultured sycamore cells by treatment with endopolygalacturonase, were tested for morphogenesis-regulating activity in a modified tobacco thin-cell-layer explant (TCL) bioassay (D. Mohnen, S. Eberhard, V. Marfa, N. Doubrava, P. Toubart, D. J. Gollin, T.A. Gruber, W. Nuri, P. Albersheim, and A. Darvill, manuscript submitted). The pectic fragments inhibited the formation of roots on TCLs grown on a root-inducing medium containing 15 micromolar indole-3-butyric acid and 0.5 micromolar kinetin. Addition of the pectic fragments to a root-inducing medium containing 7 micromolar indole-3-butyric acid and 0.15 micromolar kinetin caused roots to form on the basal end of TCLs. TCLs cultured on this medium in the absence of added pectic fragments formed roots along their entire length. The pectic fragments induced polar tissue enlargement and the formation of flowers on TCLs cultured on transition medium. The flower-inducing activity was stable to heat treatment and proteolytic digestion. Pectic fragments isolated from the walls of suspension-cultured tobacco cells were as effective as those from the walls of sycamore cells in inducing de novo flower formation in the TCLs. These results support the hypothesis that oligosaccharins from plant cell walls regulate morphogenesis.

8.
Oecologia ; 56(1): 121-125, 1983 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-28310779

RESUMEN

In common milkweed (Asclepias syriaca), flower nectar volumes, concentration and sugar production varied according to the age of the sampled blossoms. In individual blossoms, nectar production peaked daily at 0800 hr. Peak production during the life of the flower occurred on the second day of flowering, 50 h after anthesis, and nectar production ceased after 120 h. The amount and quality of nectar were affected by microclimatic conditions and varied between clones. However, the same secretory patterns were found in all flowers studied. This age dependent nectar secretion combined with the sequential mode of flowering found on a single stem, results in substantial reward for extended periods to nectar feeders.

10.
Hosp Med Staff ; 7(6): 19-26, 1978 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-10307630

RESUMEN

Procedural due process, an elusive concept based on fundamental fair play, may differ in its requirements depending on the time, place, and circumstances. Part 2 of this two-part article explains how the way in which an adversary situation is handled can be equally important as the substantive reasons for the action. Part I, which appeared in the May issue, discussed hospital rules that define and regulat an individual's rights and duties.


Asunto(s)
Privilegios del Cuerpo Médico/legislación & jurisprudencia , Cuerpo Médico de Hospitales/legislación & jurisprudencia , Administración Hospitalaria
11.
Hosp Med Staff ; 7(5): 30-7 concl, 1978 May.
Artículo en Inglés | MEDLINE | ID: mdl-10306911

RESUMEN

The physician's right to due process of law and equal protection regarding staff appointments and clinical privileges is being upheld in many state courts. Unreasonable, arbitrary, and capricious rules are the targets of court decisions. Part 1 of this two-part article focuses on hospital rules that define and regulate an individual's rights and duties. Part 2, which will appear in the June issue, will discuss procedural due process.


Asunto(s)
Derechos Civiles , Privilegios del Cuerpo Médico/legislación & jurisprudencia , Cuerpo Médico de Hospitales/legislación & jurisprudencia , Administración Hospitalaria , New Jersey , Estados Unidos
14.
Hospitals ; 45(18): 55-9, 1971 Sep 16.
Artículo en Inglés | MEDLINE | ID: mdl-5095230
15.
Hosp Prog ; 52(9): 76-86 passim, 1971 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-5571520
16.
Hospitals ; 44(17): 49-54, 1970 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-5451670
18.
Dent Clin North Am ; : 303-23, 1967 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-5229944
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...